The world has changed, and it’s not going back. Artificial Intelligence has emerged as a promising technology to revolutionise healthcare. But AI can only be effective if we provide the right infrastructure. The European Health Data Space is a major initiative that will ensure access to different types of health data, aiming to support healthcare delivery, research and policy making. For this, data should be collected with the right level of granularity, and refreshed regularly to train algorithms against bias.
We will explore how this provides an unprecedented opportunity to boost competitiveness in life sciences, and some of the technologies being developed that will thrive on new data availability.
Join experts from Janssen, OKRA and the German Federal Ministry of Health in a demonstration of what high-quality data and cutting-edge technology can do to transform healthcare as we know it.
Nick Schneider of the German Federal Ministry of Health will describe the European landscape and high-level policies towards innovation and competitiveness, with a focus on the European Health Data Space project.
Koen Torfs of Janssen Pharmaceutical Companies of Johnson & Johnson (previously Actelion) will explain how RWD powered by AI can help capture the evidence to revolutionise healthcare and the value of treatments.
Dr Loubna Bouarfa of OKRA Technologies will illustrate the role of AI in the European race towards innovation and competitiveness and the revolutionary work that OKRA is in applying AI for healthcare applications.